Home › Funds › Oxbow Advisors, LLC › REGN
Oxbow Advisors, LLC position in REGN
REGENERON PHARMACEUTICALS · Health Care
Oxbow Advisors, LLC reported holding 10,649 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 0.58% of its reported portfolio and ranking #40 among its reported holdings. Oxbow Advisors, LLC has disclosed REGN holdings in 6 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Oxbow Advisors, LLC's REGN position evolved
Oxbow Advisors, LLC first disclosed a stake in REGN in Q1 2025 at 3,653 shares (US$2.3M). The position peaked in Q3 2026 at 10,649 shares, worth US$8.1M. Across 6 filings, Oxbow Advisors, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 10,649 shares valued at US$8.1M — an increase of 5,290 shares quarter over quarter.. Notable position changes include a 99% increase in Q3 2026 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 3.65K | $2.32M | New |
| Q3 2025 | 5.25K | $2.95M | New |
| Q4 2025 | 5.33K | $4.11M | Add |
| Q1 2026 | 5.33K | $4.12M | Hold |
| Q2 2026 | 5.36K | $3.34M | Hold |
| Q3 2026 | 10.65K | $8.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on Oxbow Advisors, LLC
FAQ
How long has Oxbow Advisors, LLC held REGN?
Oxbow Advisors, LLC has disclosed REGN holdings in 6 of the last 7 reported quarters, going back to Q1 2025.
What is Oxbow Advisors, LLC's current position in REGN?
As of Q3 2026, Oxbow Advisors, LLC holds 10.65K shares of REGN (REGENERON PHARMACEUTICALS), valued at $8.08M, representing 0.58% of its reported portfolio and ranking #40.
Has Oxbow Advisors, LLC been buying or selling REGN?
In the latest 13F filing (Q3 2026), Oxbow Advisors, LLC increased its position in REGN. The position peaked in Q3 2026 at 10.65K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.